Dichotomic effects of clinically used drugs on tumor growth, bone remodeling and pain management.
Ontology highlight
ABSTRACT: Improvements in the survival of breast cancer patients have led to the emergence of bone health and pain management as key aspects of patient's quality of life. Here, we used a female rat MRMT-1 model of breast cancer-induced bone pain to compare the effects of three drugs used clinically morphine, nabilone and zoledronate on tumor progression, bone remodeling and pain relief. We found that chronic morphine reduced the mechanical hypersensitivity induced by the proliferation of the luminal B aggressive breast cancer cells in the tumor-bearing femur and prevented spinal neuronal and astrocyte activation. Using MTT cell viability assay and MRI coupled to 18FDG PET imaging followed by ex vivo 3D µCT, we further demonstrated that morphine did not directly exert tumor growth promotin
SUBMITTER: Barriere DA
PROVIDER: S-EPMC6934511 | biostudies-literature | 2019 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA